Clinical Trials Directory

Trials / Completed

CompletedNCT03698760

Computerized Olfactory Test - Alzheimer Disease Mild Stage

Calibration and Validation of a Computerized Olfactory Test in Subjects With Alzheimer's Disease in a Mild Stage

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
82 (actual)
Sponsor
Jewish General Hospital · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

This study evaluates the effectiveness of the smell tests that are used in early diagnosis of mild dementia.

Detailed description

For twenty years research has shown a strong link between olfactory disorders and Alzheimer's disease. The focus is on the very early alteration of the olfaction which acts as a harbinger of the disease since it is detectable in its asymptomatic phase. In addition, olfactory involvement is a precursor to the transformation of mild cognitive impairment into MA. Indeed the anatomical structures the first lesions are located in the transentorhinal region of the temporal lobe and entorhinal phase, before progressing towards the limbic system, which will mark the clinical appearance of the first signs of AD. In literature, it has been shown that there was no olfactory test that is recognized as a gold standard in the scientific community due to a lack of homogeneity of the tools used, their availability and their validity depending on the culture. Moreover, of all the tests currently available, none are specific to neurodegenerative diseases. Very recent studies show that there is also a strong preference for imaging tools or biomarkers in the detection of AD, but it appears that the olfactory disorders are well before these markers. It has been shown that an identification test is comparable in predictive accuracy to neuroimaging and cerebrospinal fluid sampling. This study will therefore focus on the calibration and validation of a computerized olfactory test for the diagnosis of Alzheimer's disease and based the recommendations of professionals so as to promote the effective use of this test in clinical practice.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOlfactory testOlfactory test: All fragrances tested are kept in an airtight case protected from cold and heat. The test is done on a tablet and the data will be automatically saved. The first screen is about the administrative data, sex and age of the subject. Olfactory test: six odors among the fourteen are proposed in a randomized way.

Timeline

Start date
2019-06-25
Primary completion
2020-03-05
Completion
2020-03-05
First posted
2018-10-09
Last updated
2020-07-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03698760. Inclusion in this directory is not an endorsement.